[三季报]珀莱雅(603605):珀莱雅化妆品股份有限公司2025年第三季度报告（英文版）
|
时间：2025年10月30日 23:16:00 中财网 |
|
原标题: 珀莱雅: 珀莱雅化妆品股份有限公司2025年第三季度报告（英文版）
Stock Code: 603605 Stock Abbreviation: Proya Bond Code: 113634 Bond Abbreviation: Proya Convertible Bond
Proya Cosmetics Co., Ltd.
Third Quarter Report 2025
The Board of Directors and all directors of the Company guarantee that there are no
false records, misleading statements, or material omissions in the content of this
announcement, and bear legal responsibility for the truthfulness, accuracy, and
completeness of its content.
Key Information Highlights:
The Board of Directors, all directors, and senior management of the Company hereby guarantee that the
contents of this quarterly report are true, accurate, and complete, and that there are no false records,
misleading statements, or material omissions. They shall bear individual and joint legal liability for the
authenticity, accuracy, and completeness of the information contained herein.
The person in charge of the Company, the person responsible for accounting work, and the head of the
accounting department (accounting officer) hereby guarantee that the financial information contained in
this quarterly report is true, accurate, and complete.
Were the third-quarter financial statements audited?
"□ Yes" "√ No"
I. Key Financial Data
(I) Key accounting data and financial indicators
Unit: Yuan Currency: RMB
| Item | The Reporting
Period | YOY
change in
the | From the beginning
of the year to the | YoY change
in the period
from the | | | | Reporting
Period (%) | end of the
Reporting Period | beginning of
the year to the
end of the
Reporting
Period (%) | | Operating revenue | 1,736,009,372.67 | -11.63 | 7,097,899,849.33 | 1.89 | | Total profit | 273,353,000.54 | -23.23 | 1,271,850,421.62 | 1.58 | | Net profit attributable to
shareholders of the
listed company | 227,188,720.58 | -23.64 | 1,025,700,052.65 | 2.65 | | Net profit attributable to
shareholders of the
listed company net of
non-recurring gains and
losses | 227,104,910.50 | -22.30 | 997,706,043.78 | 2.72 | | Net cash flows from
operating activities | Not applicable | Not
applicable | 1,198,467,218.63 | 196.65 | | Basic earnings per share
(RMB/share) | 0.57 | -24.00 | 2.59 | 2.37 | | Diluted earnings per
share (RMB/share) | 0.57 | -24.00 | 2.59 | 3.60 | | Weighted average ROE
(%) | 3.96 | down by
2.38
percentage
points | 18.25 | down by 3.49
percentage
points | | | End of the
Reporting Period | End of prior year | Change at the
end of the
Reporting
Period over
the end of the
prior year (%) | | | Total assets | 8,574,809,697.11 | 7,530,182,694.00 | 13.87 | | | Owners’ Equity
attributable to
shareholders of the
listed company | 5,668,548,299.68 | 5,402,074,485.07 | 4.93 | |
Note: The “Reporting Period” refers to the three-month period from the beginning of this quarter to the
end of this current quarter, as follows.
(II) Items and amounts of non-recurring gains and losses
"√ Not applicable" "□ Not applicable"
Unit: Yuan Currency: RMB
| Non-recurring profit and loss item | Amount for the
current period | Amount in the
period from the
beginning of the
year to the end of
the Reporting
Period | Remarks | | Gains or losses arising from disposal
of non-current assets, including write-
offs of provision for asset impairment
accrued | -301,417.58 | -647,921.76 | | | Government grants included in
current profit or loss (excluding
government grants that are closely
related to the Company’s normal
business operations, compliant with
national policies, granted at set
standards, and imposing sustaining
influence on the Company's profit or
loss) | 403,523.99 | 51,080,833.99 | | | Gains or losses arising from change in
fair value generated by financial
assets and financial liabilities held by
non-financial enterprises, as well as
gains or losses arising from disposal
of financial assets and financial
liabilities, except for valid hedging
business related to the Company's
normal business operations | | | | | Capital occupation fees charged to
non-financial enterprises and included
in current profit or loss | | | | | Gains or losses on authorizing others
to invest or manage assets | | | | | Gains or losses arising from entrusted
loans to external parties | | | | | Asset loss incurred by force majeure
such as natural disasters | | | | | Reversal of provision for impairment
of receivables individually tested for
impairment | | | | | Gains arising when the investment
cost of acquiring a subsidiary, an
associate or a joint venture is less than | | | | | the fair value of the identifiable net
assets of the investee | | | | | Net profit or loss of subsidiaries
arising from business combinations
under common control, for the period
from the beginning of the Reporting
Period to the combination date | | | | | Gains or losses arising from exchange
of non-monetary assets | | | | | Gains or losses arising from debt
restructuring | | | | | One-off expenses incurred due to the
cessation of relevant operating
activities, such as staffing expenses | | | | | One-off impact on current profit or
loss resulting from adjustments in tax,
accounting, or other laws and
regulations | | | | | One-off share-based payment
recognized for cancellation and
modification of equity incentive plans | | | | | Gains or losses arising from changes
in the fair value of employee
remuneration payable under cash-
settled share-based payment after the
vesting date | | | | | Gains or losses arising from changes
in the fair value of investment
property subsequently measured with
the fair value model | | | | | Gains arising from transactions with
unreasonable transaction price | | | | | Gains or losses arising from
contingencies unrelated to the
Company's normal business
operations | | | | | Custody fee income from entrusted
operations | | | | | Other non-operating revenue and
expenses besides the above items | 43,089.20 | -639,967.70 | | | Other gains and losses items that
conform to the definition of non-
recurring gains and losses | | | | | Less: Effect of income tax | 31,240.36 | 12,560,858.24 | | | Impact of minority interests
(after tax) | 30,145.17 | 9,238,077.42 | | | Total | 83,810.08 | 27,994,008.87 | |
The reasons should be explained for the Company defining items not listed in the Explanatory Announcement on Information Disclosure for Companies Offering Their Securities to the Public No. 1 –
Non-Recurring Gains and Losses as non-recurring gains and losses items of high value, and defining the
non-recurring gains and losses items listed in the same document as recurring gains and losses items.
"□ Applicable" "√ Not applicable"
(III) Changes in key accounting data and financial indicators and reasons "√ Not applicable" "□ Not applicable"
| Item | Change ratio
(%) | Primary reasons | | Net cash flows from
operating activities - from
the beginning of the year
to the end of the
Reporting Period | 196.65 | Mainly due to: 1. An increase in cash received from
sales of goods; 2. A decrease in payments for goods
purchased. |
II. Shareholders Information
(I) Total number of ordinary shareholders, number of shareholders of preference shares whose voting rights have been restored, and top ten shareholders holding shares Unit: Share
| Total number of ordinary
shareholders at the end of
the Reporting Period | 84,093 | Total number of shareholders of
preference shares whose voting rights
have been restored at the end of the
Reporting Period (if any) | 0 | | | | | Shareholdings of the top ten shareholders (excluding securities lending and refinancing) | | | | | | | | Name of shareholder | Nature of
shareholders | Number
of shares
held | Shareholding
ratio (%) | Number of
restricted
shares
held | Pledged, marked
or frozen | | | | | | | | Share
status | Number | | HOU Juncheng | Domestic
natural person | 136,739,
037 | 34.53 | 0 | None | | | FANG Yuyou | Domestic
natural person | 59,625,2
58 | 15.06 | 0 | Frozen | 17,041,2
69 | | Hong Kong Securities
Clearing Company Limited | Others | 27,110,6
29 | 6.85 | 0 | None | | | Agricultural Bank of China
Limited – CSI 500
Exchange Traded Open-
End Index Securities
Investment Fund | Others | 3,464,78
7 | 0.87 | 0 | None | | | Industrial and Commercial
Bank of China Limited -
Invesco Great Wall
Emerging Growth Hybrid
Securities Investment Fund | Others | 3,332,00
0 | 0.84 | 0 | None | | | Industrial and Commercial
Bank of China Limited –
Dongfanghong Ruixi
Three-Year Holding Period
Hybrid Securities
Investment Fund | Others | 3,251,94
0 | 0.82 | 0 | None | | | Industrial and Commercial
Bank of China Limited –
CSI Major Consumer
Exchange Traded Open-
End Index Securities
Investment Fund | Others | 3,012,10
0 | 0.76 | 0 | None | | | China Construction Bank
Co., Ltd. - CUAM
Consumer Industry Hybrid
Securities Investment Fund | Others | 2,000,00
2 | 0.51 | 0 | None | | | Schroder Investment
Management (Hong Kong)
Limited - Schroder
International Selection
Fund China A-share (stock
exchange) | Others | 1,961,80
0 | 0.50 | 0 | None | | | China Life Insurance Co.,
Ltd. – Traditional –
Ordinary Insurance
Products – 005L – CT001
Shanghai | Others | 1,937,54
4 | 0.49 | 0 | None | | | Shareholdings of the top ten unrestricted shareholders (excluding securities lending and refinancing) | | | | | | | | Name of shareholder | Number of unrestricted circulating shares
held | Type and number of shares | | | | | | | | Type of
shares | Number | | | | | HOU Juncheng | 136,739,037 | RMB
ordinary
shares | 136,739,037 | | | |
| FANG Yuyou | 59,625,258 | RMB
ordinary
shares | 59,625,258 | | Hong Kong Securities
Clearing Company Limited | 27,110,629 | RMB
ordinary
shares | 27,110,629 | | Agricultural Bank of China
Limited – CSI 500
Exchange Traded Open-
End Index Securities
Investment Fund | 3,464,787 | RMB
ordinary
shares | 3,464,787 | | Industrial and Commercial
Bank of China Limited -
Invesco Great Wall
Emerging Growth Hybrid
Securities Investment Fund | 3,332,000 | RMB
ordinary
shares | 3,332,000 | | Industrial and Commercial
Bank of China Limited –
Dongfanghong Ruixi
Three-Year Holding Period
Hybrid Securities
Investment Fund | 3,251,940 | RMB
ordinary
shares | 3,251,940 | | Industrial and Commercial
Bank of China Limited –
CSI Major Consumer
Exchange Traded Open-
End Index Securities
Investment Fund | 3,012,100 | RMB
ordinary
shares | 3,012,100 | | China Construction Bank
Co., Ltd. - CUAM
Consumer Industry Hybrid
Securities Investment Fund | 2,000,002 | RMB
ordinary
shares | 2,000,002 | | Schroder Investment
Management (Hong Kong)
Limited - Schroder
International Selection
Fund China A-share (stock
exchange) | 1,961,800 | RMB
ordinary
shares | 1,961,800 | | China Life Insurance Co.,
Ltd. – Traditional –
Ordinary Insurance
Products – 005L – CT001
Shanghai | 1,937,544 | RMB
ordinary
shares | 1,937,544 |
| Explanation on the
association or concerted
action among the
shareholders mentioned
above | FANG Yuyou is the younger brother of HOU Juncheng's spouse FANG
Aiqin, so HOU Juncheng and FANG Yuyou are associated. | | Explanation on the
securities lending and
refinancing among the top
ten shareholders and top
ten unrestricted
shareholders (if any) | Not applicable |
Note: As of the end of the Reporting Period, 2,210,825 shares of the Company were held in the Company's
special securities account for repurchase, representing 0.56% of the total share capital of the Company.
Securities lending and refinancing involved by shareholders holding more than 5% shares, the top ten
shareholders and the top ten shareholders of unrestricted circulating shares "□ Applicable" "√ Not applicable"
Change in the top ten shareholders and the top ten shareholders of unrestricted circulating shares over the
previous period due to securities lending and refinancing/their returning "□ Applicable" "√ Not applicable"
III. Other Matters to Note
Other important information regarding the Company’s operating performance during the Reporting Period
that investors should be aware of.
"□ Applicable" "√ Not applicable"
IV. Quarterly Financial Statements
(I) Type of audit opinion
"□ Applicable" "√ Not applicable"
(II) Financial statements
Consolidated Balance Sheet
September 30, 2025
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB Type of Audit: Unaudited
| Item | September 30, 2025 | December 31, 2024 | | Current assets: | | | | Monetary capital | 4,482,429,082.19 | 4,082,126,416.84 | | Provision for settlement | | | | Placements with banks and other
financial institutions | | | | Financial assets held for trading | | | | Derivative financial assets | | | | Notes receivable | | | | Accounts receivable | 318,499,272.25 | 517,954,587.12 | | Receivables financing | 1,221,062.00 | | | Prepayments | 279,423,583.14 | 223,879,388.67 | | Premiums receivable | | | | Reinsurance accounts receivable | | | | Provision for reinsurance contract
receivables | | | | Other receivables | 11,746,960.71 | 9,869,822.71 | | Including: Interest receivable | | | | Dividends receivable | | | | Financial assets purchased under resale
agreements | | | | Inventory | 976,259,283.67 | 661,410,153.37 | | Including: Data resources | | | | Contract assets | | | | Assets held for sale | | | | Non-current assets due within one year | | | | Other current assets | 142,290,073.09 | 118,117,428.18 | | Total current assets | 6,211,869,317.05 | 5,613,357,796.89 | | Non-current assets: | | | | Loans and advances to customers | | | | Debt investments | | | | Other debt investments | | | | Long-term receivables | | | | Long-term equity investments | 431,448,336.37 | 111,090,815.70 | | Other equity instrument investments | 81,256,995.18 | 71,256,995.18 | | Other non-current financial assets | | | | Investment property | 62,041,914.81 | 63,537,443.20 | | Fixed assets | 876,929,898.61 | 907,224,090.94 | | Construction in progress | 117,921,464.80 | 74,585,001.38 | | Productive biological assets | | | | Oil and gas assets | | | | Right-of-use assets | 19,582,489.43 | 14,541,665.50 | | Intangible assets | 418,117,646.16 | 429,394,857.15 | | Including: Data resources | | | | Development expenditure | | | | Including: Data resources | | | | Goodwill | | | | Long-term deferred expenses | 111,457,435.14 | 70,202,612.96 | | Deferred income tax assets | 210,095,626.90 | 163,733,011.95 | | Other non-current assets | 34,088,572.66 | 11,258,403.15 | | Total non-current assets | 2,362,940,380.06 | 1,916,824,897.11 | | Total assets | 8,574,809,697.11 | 7,530,182,694.00 | | Current liabilities: | | | | Short-term borrowings | 80,024,000.00 | | | Borrowings from the central bank | | | | Placements from banks and other
financial institutions | | | | Financial liabilities held for trading | | | | Derivative financial liabilities | | | | Notes payable | | | | Accounts payable | 1,014,873,964.55 | 676,388,126.18 | | Receipts in advance | 311,033.47 | 129,400.52 | | Contract liabilities | 220,623,450.59 | 153,710,588.62 | | Financial assets sold under repurchase
agreements | | | | Customer deposits and deposits from
banks and other financial institutions | | | | Funds from securities trading agencies | | | | Funds from underwriting securities
agencies | | | | Employee remuneration payable | 124,742,567.53 | 155,703,420.95 | | Taxes payable | 142,952,016.90 | 125,853,371.28 | | Other payables | 350,782,184.58 | 91,776,722.59 | | Including: Interest payable | | | | Dividends payable | 315,035,573.60 | | | Fees and commissions payable | | | | Reinsurance accounts payable | | | | Held-for-sale liabilities | | | | Non-current liabilities due within one
year | 4,775,968.41 | 3,473,806.48 | | Other current liabilities | 6,614,954.55 | 5,509,508.59 | | Total current liabilities | 1,945,700,140.58 | 1,212,544,945.21 | | Non-current liabilities: | | | | Insurance contract reserves | | | | Long-term borrowings | | | | Bonds payable | 806,619,068.46 | 780,011,293.32 | | Including: Preference shares | | | | Perpetual bonds | | | | Lease liabilities | 14,599,911.65 | 10,955,380.12 | | Long-term payables | | | | Long-term employee remuneration
payable | | | | Estimated liabilities | 11,728,682.67 | 25,162,463.80 | | Deferred income | 17,106,593.83 | 15,260,760.59 | | Deferred income tax liabilities | 438,756.97 | | | Other non-current liabilities | | | | Total non-current liabilities | 850,493,013.58 | 831,389,897.83 | | Total liabilities | 2,796,193,154.16 | 2,043,934,843.04 | | Owner's equity (or shareholders' equity): | | | | Paid-in capital (or share capital) | 396,005,282.00 | 396,247,555.00 | | Other equity instruments | 50,890,526.72 | 50,891,546.26 | | Including: Preference shares | | | | Perpetual bonds | | | | Capital reserve | 826,796,738.87 | 846,600,405.28 | | Less: Treasury shares | 193,700,268.42 | 238,275,443.41 | | Other comprehensive income | -84,720,033.83 | -84,904,946.54 | | Special reserve | | | | Surplus reserve | 198,411,582.50 | 198,411,582.50 | | General risk reserve | | | | Undistributed profits | 4,474,864,471.84 | 4,233,103,785.98 | | Total owner's equity (or shareholders'
equity) attributable to the parent company | 5,668,548,299.68 | 5,402,074,485.07 | | Minority interests | 110,068,243.27 | 84,173,365.89 | | Total owner's equity (or shareholders'
equity) | 5,778,616,542.95 | 5,486,247,850.96 | | Total liabilities and owners' equity
(or shareholders' equity) | 8,574,809,697.11 | 7,530,182,694.00 |
Company Representative: HOU Juncheng Accounting Work Representative: JIN Chang Accounting Department Representative: MA Nan
Consolidated Income Statement
2025 M1-M9
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB Type of Audit: Unaudited
| Item | First three quarters of
2025
(M1-M9) | First three quarters of
2024
(M1-M9) | | I. Total operating revenue | 7,097,899,849.33 | 6,966,033,360.37 | | Including: Operating revenue | 7,097,899,849.33 | 6,966,033,360.37 | | Interest income | | | | Premiums earned | | | | Fees and commission income | | | | II. Total operating costs | 5,855,768,198.52 | 5,744,357,919.86 | | Including: Operating costs | 1,867,128,487.97 | 2,084,884,015.50 | | Interest expenses | | | | Fees and commissions expenses | | | | Surrenders | | | | Net compensation expenses | | | | Net provision for insurance liability
reserves | | | | Insurance policy dividend expenses | | | | Reinsurance expenses | | | | Taxes and surcharges | 60,565,990.35 | 52,714,418.79 | | Sales expenses | 3,525,239,516.44 | 3,231,672,618.81 | | Administrative expenses | 290,164,810.57 | 272,663,396.32 | | R&D expenses | 141,892,170.50 | 142,437,776.25 | | Financial expenses | -29,222,777.31 | -40,014,305.81 | | Including: Interest expenses | 23,914,050.19 | 15,476,254.24 | | Interest income | 46,750,608.77 | 56,625,021.91 | | Add: Other income | 57,237,116.15 | 71,782,997.31 | | Investment income (“-” for losses) | 6,420,566.35 | -3,153,663.74 | | Including: Investment income from
associates and joint ventures | 11,444,227.90 | -3,153,663.74 | | Gains from derecognition of
financial assets measured at amortized cost | | | | Foreign exchange gains (“-” for
losses) | | | | Net gain on exposure hedging (“-”
for losses) | | | | Gains on changes in fair value (“-”
for losses) | | | | Credit impairment losses (“-” for
losses) | 7,287,063.65 | 4,634,528.68 | | Asset impairment losses (“-” for
losses) | -40,003,598.59 | -42,109,077.10 | | Gains from disposal of assets (“-”
for losses) | -647,921.76 | -758,751.64 | | III. Operating profit (“-” for losses) | 1,272,424,876.61 | 1,252,071,474.02 | | Add: Non-operating revenue | 721,299.11 | 1,673,416.25 | | Less: Non-operating expenses | 1,295,754.10 | 1,615,716.02 | | IV. Total profit (“-” for total losses) | 1,271,850,421.62 | 1,252,129,174.25 | | Less: Income tax expenses | 216,849,451.38 | 229,730,454.71 | | V. Net profit (“-” for net losses) | 1,055,000,970.24 | 1,022,398,719.54 | | (I) Classified by operation continuity | | | | 1. Net profit from continuing
operations (“-” for net losses) | 1,055,000,970.24 | 1,022,398,719.54 | | 2. Net profit from discontinued
operations (“-” for net losses) | | | | (II) Classified by ownership | | | | 1. Net profit attributable to
shareholders of the parent company (“-”
for net losses) | 1,025,700,052.65 | 999,209,386.88 | | 2. Profit or loss attributable to
minority interests (“-” for net losses) | 29,300,917.59 | 23,189,332.66 | | VI. Other comprehensive income, net of
tax | 184,912.71 | 230,418.26 | | (I) Other comprehensive income
attributable to owners of the parent
company, net of tax | 184,912.71 | 230,418.26 | | 1.Other comprehensive income that
cannot be reclassified into profit or loss | | | | (1) Changes arising from re-
measurement of defined benefit plans | | | | (2) Other comprehensive income that
cannot be reclassified into profit or loss
under the equity method | | | | (3) Changes in the fair value of other
equity instrument investments | | | | (4) Changes in the fair value of the
Company's own credit risks | | | | 2. Other comprehensive income that
will be reclassified into profit or loss | 184,912.71 | 230,418.26 | | (1) Other comprehensive income that
can be reclassified into profit or loss under
the equity method | | | | (2) Changes in the fair value of other
debt investments | | | | (3) Amount of financial assets
reclassified into other comprehensive
income | | | | (4) Credit impairment provisions of
other debt investments | | | | (5) Cash flow hedging reserve | | | | (6) Conversion differences of
financial statements denominated in
foreign currencies | 184,912.71 | 230,418.26 | | (7) Others | | | | (II) Other comprehensive income
attributable to minority interests, net of tax | | | | VII. Total comprehensive income | 1,055,185,882.95 | 1,022,629,137.80 | | (I) Total comprehensive income
attributable to owners of the parent
company | 1,025,884,965.36 | 999,439,805.14 | | (II) Total comprehensive income
attributable to minority interests | 29,300,917.59 | 23,189,332.66 | | VIII. Earnings per share: | | | | (I) Basic earnings per share
(RMB/share) | 2.59 | 2.53 | | (II) Diluted earnings per share
(RMB/share) | 2.59 | 2.50 |
Company Representative: HOU Juncheng Accounting Work Representative: JIN Chang Accounting Department Representative: MA Nan
Consolidated Cash Flow Statement
2025 M1-M9
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB Type of Audit: Unaudited
| Item | First three quarters of
2025
(M1-M9) | First three quarters of
2024
(M1-M9) | | I. Cash flows from operating activities: | | | | Cash receipts from sales of goods and
rendering of services | 8,048,869,273.19 | 7,522,400,703.39 | | Net increase in customer deposits and
deposits from banks and other financial
institutions | | | | Net increase in borrowings from the central
bank | | | | Net increase in placements from other
financial institutions | | | | Cash receipts from premiums under
original insurance contracts | | | | Net cash receipts from reinsurance
business | | | | Net increase in deposits and investments
from policyholders | | | | Cash receipts from interest, fees and
commissions | | | | Net increase in placements from banks and
other financial institutions | | | | Net increase of returned business capital | | | | Net cash receipts from securities trading
agency services | | | | Receipts of tax refunds | 2,204,162.73 | 938,267.15 | | Other cash receipts relating to operating
activities | 130,064,405.75 | 122,873,031.65 | | Subtotal of cash inflows from operating
activities | 8,181,137,841.67 | 7,646,212,002.19 | | Cash payments for goods purchased and
services received | 1,710,978,811.90 | 2,114,302,093.57 | | Net increase in loans and advances to
customers | | | | Net increase in deposits with the central
bank and other financial institutions | | | | Cash paid for compensation payments
under original insurance contract | | | | Net increase in placements with banks and
other financial institutions | | | | Cash payments for interest, fees and
commissions | | | | Cash payments for policy dividends | | | | Cash payments to and on behalf of
employees | 721,570,038.36 | 631,419,914.74 | | Taxes and fees paid | 774,357,744.04 | 822,656,497.25 | | Other cash payments relating to operating
activities | 3,775,764,028.74 | 3,673,835,455.60 | | Subtotal of cash outflows from operating
activities | 6,982,670,623.04 | 7,242,213,961.16 | | Net cash flows from operating
activities | 1,198,467,218.63 | 403,998,041.03 | | II. Cash flows from investing activities: | | | | Cash receipts from returns on investments | 99,990,000.00 | | | Cash receipts from investments income | 15,999,900.00 | 5,570,000.01 | | Net cash receipts from disposal of fixed
assets, intangible assets and other long-term
assets | 2,147,103.67 | 1,831,479.00 | | Net cash receipts from the disposal of
subsidiaries and other operating entities | 7,850,000.00 | | | Other cash receipts relating to investing
activities | 102,075,000.00 | 300,000,000.00 | | Subtotal of cash inflows from investing
activities | 228,062,003.67 | 307,401,479.01 | | Cash payments for purchase and
construction of fixed assets, intangible assets
and other long-term assets | 92,266,560.21 | 154,362,742.03 | | Cash payments for investments | 437,975,763.00 | | | Net increase in pledged loans | | | | Net cash payments for acquisition of
subsidiaries and other operating entities | | | | Other cash payments relating to investing
activities | | 1,180,000,000.00 | | Subtotal of cash outflows from investing
activities | 530,242,323.21 | 1,334,362,742.03 | | Net cash flows from investing
activities | -302,180,319.54 | -1,026,961,263.02 | | III. Cash flows from financing activities: | | | | Cash receipts from capital contributions | 286,400.00 | 125,051.00 | | Including: Cash receipts by subsidiaries
from minority shareholders’ investment | 286,400.00 | 125,051.00 | | Cash receipts from borrowings | 80,000,000.00 | | | Other cash receipts relating to financing
activities | | | | Subtotal of cash inflows from financing
activities | 80,286,400.00 | 125,051.00 | | Cash payments for debt repayment | | 100,000,000.00 | | Cash payments for distribution of
dividends, profits or payment of interest
expenses | 472,596,233.39 | 362,965,173.73 | | Including: Dividends and profits paid by
subsidiaries to minority shareholders | 3,692,440.20 | | | Other cash payments relating to financing
activities | 18,774,674.26 | 184,292,170.36 | | Subtotal of cash outflows from financing
activities | 491,370,907.65 | 647,257,344.09 | | Net cash flows from financing
activities | -411,084,507.65 | -647,132,293.09 | | IV. Effect of changes in foreign exchange
rates on cash and cash equivalents | 184,912.71 | 230,418.26 | | V. Net increase in cash and cash
equivalents | 485,387,304.15 | -1,269,865,096.82 | | Add: Opening balance of cash and cash
equivalents | 2,742,569,684.62 | 3,659,267,712.03 | | VI. Closing balance of cash and cash
equivalents | 3,227,956,988.77 | 2,389,402,615.21 |
Company Representative: HOU Juncheng Accounting Work Representative: JIN Chang Accounting Department Representative: MA Nan （未完）
|
|
